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fracture nonunions of superficial bones:
a retrospective case series
Paulo Kertzman1, Nikolaus B. M. Császár2, John P. Furia3 and Christoph Schmitz2*
Abstract
Background: A substantial body of evidence supports the use of focused extracorporeal shock wave therapy
(fESWT) in the non-invasive treatment of fracture nonunions. On the other hand, virtually no studies exist on the
use of radial extracorporeal shock wave therapy (rESWT) for this indication.
Methods: We retrospectively analyzed 22 patients treated with rESWT for fracture nonunions of superficial bones
that failed to heal despite initial surgical fixation in most cases. Radial extracorporeal shock wave therapy was applied
without anesthesia in three rESWT sessions on average, with one rESWT session per week and 3000 radial
extracorporeal shock waves at an energy flux density of 0.18 mJ/mm2 per session. Treatment success was
monitored with radiographs and clinical examinations.
Results: Six months after rESWT radiographic union was confirmed in 16 out of 22 patients (73%), which is
similar to the success rate achieved in comparable studies using fESWT. There were no side effects. The tibia
was the most common treatment site (10/22) and 70% of tibia nonunions healed within 6 months after rESWT. Overall,
successfully treated patients showed a mean time interval of 8.8 ± 0.8 (mean ± standard error of the mean) months
between initial fracture and commencement of rESWT whereas in unsuccessfully treated patients the mean interval
was 26.0 ± 10.1 months (p < 0.05). In unsuccessful tibia cases, the mean interval was 43.3 ± 13.9 months.
Conclusions: Radial extracorporeal shock wave therapy appears to be an effective and safe alternative in the
management of fracture nonunions of superficial bones if diagnosed early and no fESWT device is available.
The promising preliminary results of the present case series should encourage the implementation of randomized
controlled trials for the early use of rESWT in fracture nonunions.
Keywords: Bone, Focused extracorporeal shock wave therapy, Fracture, Nonunion, Radial extracorporeal shock
wave therapy
Background
Nonunion refers to the failure of bone fractures to
achieve cortical continuity on radiographic studies. The
prevalence of nonunion of all fracture types ranges from
2.5 to 46%, and the complication places substantial
economic burdens on health systems [1–3]. Surgical
fracture stabilization using bone grafts and internal/ex-
ternal fixation has remained the gold standard for treat-
ing fracture nonunions. However, these procedures often
lead to serious complications including deep infections,
persistent wound drainage, hematoma formation, sen-
sory loss, persisting pain, and nonunions [2, 4–6].
Hence, there remains a need for efficient therapies that
will bring better results more quickly and without major
complications. Over the past decades, extracorporeal
shock wave therapy (ESWT) has emerged as an efficient,
non-invasive and cost-effective alternative to surgery in
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the treatment of fracture nonunions. There are two
forms of ESWT available, focused (fESWT) and radial
(rESWT) (see [7–9] for detailed reviews). In very brief,
fESWT makes use of single acoustic pulses that are
generated either with a spark-gap (electrohydraulic
principle), a technology similar to a loudspeaker (elec-
tromagnetic principle), or piezocrystals (piezoelectric
principle). By means of reflectors of certain shape, the
acoustic pulses are converted into a focused acoustic
pressure wave/shock wave with a point of highest pres-
sure at the desired target within pathological tissue. In
case of rESWT, a projectile is fired within a guiding tube
that strikes a metal applicator placed on the skin. The
projectile generates stress waves in the applicator that
transmit pressure waves into tissue. Both focused and
radial extracorporeal shock waves are single acoustic
impulses with an initial high positive peak pressure
between 10 and 100 MPa reached in less than 1 μs. The
positive pressure amplitude is followed by a low tensile
amplitude of a few microseconds duration that can
generate cavitation. They are further characterized by a
short life cycle of approximately 10–20 μs and a broad
frequency spectrum (see [7–9] for more details).
A total of 40 studies [10–49] have shown an overall
success rate of approximately 76% after 6 months when
treating fracture nonunions with fESWT, without major
complications (Table 1; a comprehensive overview on
details of these studies is provided in Additional file 1).
Among these 40 studies were 1 randomized controlled
trial (RCT) with a success rate of 71% after 6 months
[10], 2 cohort studies comparing fESWT with surgery,
with success rates of 91 [11] and 79% [12] after
6 months, and 37 case series without control group
[13–49]. The RCT [10] and the cohort studies [11, 12]
were recently reviewed in detail elsewhere [50].
In contrast, there are only few reports of using rESWT
for treating fracture nonunions. We are aware of only
one case report study demonstrating the success of
rESWT in the consolidation of fracture nonunions
involving the base of the second metatarsal in two
professional dancers [51].
Acknowledging recent findings (i) from an animal
study in vivo demonstrating that radial extracorporeal
shock waves (rESWs) can induce new bone formation
[52] as well as (ii) from an in vitro study showing that
rESWs can induce proliferation of human osteoblast like
cells (MG63) [53], the purpose of the present study was
to test the following hypothesis: radial extracorporeal
shock waves can stimulate bone healing in fracture
nonunions of superficial bones.
Methods
The present study represents a retrospective case series
in 22 patients investigating the effects of rESWT on
fracture nonunions between 2007 and 2012. The study
was approved by the ethics committee of the Medical
School of Santa Casa de São Paulo (São Paulo, Brazil)
(Reference numbers 12558513.1.0000.5479 CAAE and
232.292 from 27 March 2013). Informed consent was
achieved from each patient to participate in this study.
In line with several reports on fESWT for facture
nonunions in the literature [11, 37, 39, 43], a nonunion
was defined as a fracture that has failed to show
continuity of three of four cortices after surgical or
nonsurgical treatment for six or more months from the
time of the fracture-related injury, or has failed to dem-
onstrate any radiographic change (improvement) for
three consecutive months, and is associated with clinical
findings consistent with a fracture nonunion (an inability
to bear weight on the affected extremity, pain on palpa-
tion, or motion at the fracture site for 3 to 6 months or
more following the incident traumatic event or the last
surgical procedure. Patients included 9 females and 13
males, with a mean age of 35.3 ± 3.5 years (mean ± stand-
ard error of the mean) (range 14 to 69) (Table 2).
Twenty of these patients had undergone initial surgical
treatment of the fracture and presented to the first
author of the present study at different time points post-
operatively (months to years) due to persisting pain and
functional limitations. Fracture nonunion sites in these
patients included the clavicle (i.e., collarbone; one
patient), ulna (one patient), carpal scaphoid (one
patient), tibia (10 patients, one of whom with an
infected/atrophic tibia), medial malleolus (two patients),
lateral malleolus (one patient), navicular bone of the foot
(one patient), second metatarsal bone (one patient), and
fifth metatarsal bone (two patients). Surgical procedures
included internal plates, nails, and intramedullary/in-
ternal screw fixations. The remaining two patients, one
with an inferior iliac crest fracture and one with a fibula
fracture, presented to the first author of the present
study, respectively, 7 and 8 months after the trauma
without receiving initial surgery.
All patients received their first rESWT treatment
between May 2007 and September 2012. The standard pro-
cedure for rESWT in the present study consisted of three
consecutive outpatient clinic rESWT sessions in 1-week
intervals, although the number of rESWT sessions was
adjusted to each patients’ individual clinical situation
(Table 2). Radial ESWT was performed without anesthesia
using a Swiss DolorClast device (Electro Medical Systems,
Nyon, Switzerland) and consisted of 3000 radial extracor-
poreal shock waves per session at the device’s highest
energy setting (i.e., 4 bar air pressure equivalent to an
energy flux density, EFD, of 0.18 mJ/mm2). The “radial”
handpiece of the device with its 15-mm applicator was used
in all cases. In each case, the point of application was deter-
mined prior to rESWT by means of radiographs and
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Table 1 Overview on all studies investigating the effects of focused extracorporeal shock wave therapy (fESWT) for fracture
nonunions listed in PubMed (as of March 01, 2017)
R Study T n D Interval
[months]
SRM6
[%]
SRT
[%]
NS NfESWs/S EFD
[mJ/mm2]
EFDT
[mJ/mm2]
Relative EFDT KV
[10] Cacchio et al. (2009) RCT 84 EM 11.1 71 94 4 4000 0.55 8800 12.1
[11] Furia et al. (2010) CH 23 EH 10.4 91 91 1 3000 0.35 1050 1.4 26
[12] Notarnicola et al. (2010) CH 58 EM 14.8 79 79 3 4000 0.09 1080 1.5
[13] Valchanou and Michailov (1991) CS 79 EH 20.2 85 1 2500
[14] Schleberger and Senge (1992) CS 4 EH ≥ 5 75 75 1 2000 18
[15] Heinrichs et al. (1993) CS 53 EM 67 1 5750
[16] Diesch & Haupt (1997) CS 172 EH, EM 66 66 1 2500 0.33 813 1.1
[17] Haupt (1997) CS 100 EH 65
[18] Haupt (1997) CS 87 EH 67 1 2000 21
[19] Vogel et al. (1997) CS 52 52
[20] Vogel et al. (1997) CS 48 EM 12 60 1 3000 0.6 1800 2.5
[21] Beutler et al. (1999) CS 25 EH 9 41 41 2 2000 18
[22] Rompe et al. (2001) CS 43 EM 11.4 72 1 3000 0.6 1800 2.5
[23] Schaden et al. (2001) CS 115 EH 6 76 1 6500 0.33 2113 2.9 24
[24] Wang et al. (2001) CS 72 EH 61 80 1 3500 0.55 1908 2.6
[25] Küfer et al. (2002) CS 4 EM ≥ 6 75 3 2500 0.12 900 1.2
[26] Schatz et al. (2002) CS 31 EM 10.5 68 1 6000 1.5 9000 12.3
[27] Biedermann et al. (2003) CS 73 EH 6 56 1 2900 0.7 2030 2.8
[28] Chooi and Penafort (2004) CS 5 EH 26.6 40 40 1 4000 25
[29] Schaden et al. (2004) CS 613 EH 16.1 76 76 1 3000 0.38 1140 1.6
[30] Bara and Synder (2007) CS 81 EH 8 83 83 1 2250 20
[31] Taki et al. (2007) CS 5 EH 12 100 100 1 3000 0.35 1050 1.4 25
[32] Endres et al. (2008) CS 1 EM 9 100 100 4 0.4
[33] Cacchio et al. (2009) CS 34 EM 6 77 77 4 4000 0.4 6400 8.8
[34] Moretti et al. (2009) CS 204 EM 85 85 1 4000 0.66 2640 3.6
[35] Wang et al. (2009) CS 42 EH 15 79 79 1 6000 0.62 3720 5.1 28
[36] Xu et al. (2009) CS 69 EM 12.5 65 76 1 6500 0.59 3835 5.3 26
[37] Elster et al. (2010) CS 192 EH 16.8 72 72 1 7000 0.39 3100 4.2 27
[38] Alvarez et al. (2011) CS 32 EH 7 73 95 1 2000 0.37 730 1
[39] Stojadinovic et al. (2011) CS 349 EH 81 81 1 7000 0.5 3500 4.8 27
[40] Vulpiani et al. (2012) CS 143 EM 14.1 56 6 2750 0.55 8301 11.2
[41] Czarnowska-Cubała et al. (2013) CS 31 EH 22.6 39 39 1 3000 20.5
[42] Alkhawashki (2015) CS 44 EH 11.9 76 1 3000 26
[43] Kuo et al. (2015) CS 22 EH 10.5 64 1 6000 0.58 3480 4.8 28
[44] Haffner et al. (2016) CS 52 EH 15.6 89 1 4000 0.4 1600 2.2
[45] Ikeda et al. (1999) CS 6 a 14 67
[46] Ikeda (2009) CS 8 a 63
R reference number, T type of study, RCT randomized controlled trial, CH cohort study, CS case series, n number of patients treated with fESWT, D type of fESWT
device, EH electrohydraulic fESWT device, EM electromagnetic fESWT device, interval interval between initial fracture and first nonunion treatment (fESWT or
other), SRM6 success rate after 6 months, SRT total success rate, NS number of fESWT sessions, NfESWs/S number of focused extracorporeal shock waves per session,
EFD energy flux density of the applied fESWs, EFDT total energy flux density, relative EFDT multiple of EFDT compared to the EFDT applied in [38], KV kilovolt. Note
that for NS, NfESWs/S, EFD, EFDT, and KV average values are provided in case more than one fESWT protocol was used in the corresponding study (details are
provided in Additional file 1). In case no data are shown, they were either not provided in the corresponding study or could not be calculated (details are
provided in Additional file 1). Note that the following studies are not listed in the table: [47] (same data as in [19]), [48] (same data as in [22]) and [49] (dataset
included in [30])
aExtracorporeal shock waves generated by means of explosions
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palpation. After rESWT, patients with metatarsal fractures
were advised to wear an open toe cast shoe for 3 weeks
whereas patients with tibia fractures were advised to refrain
from weight bearing and any sports activities for 4 weeks.
During the following 6 months patients were monitored by
means of radiographs and clinical examinations.
A positive therapy outcome was defined by radio-
graphic consolidation and absence of both pain and
functional limitations during normal weight loading
6 months after commencement of rESWT. Adverse
events during and after rESWT were documented.
Mean and standard error of the mean (SEM) of
patient’s age, number of rESWT sessions, and interval
between the initial fracture and the first rESWT session
were separately calculated for patients with positive
clinical outcome (Group rESWT+) and patients with
negative clinical outcome (group rESWT-). The Shapiro-
Wilk normality test was used to determine whether the
distribution of patients’ age, the interval between the
initial fracture and the first rESWT session, and the
number of rESWT sessions of the patients in Groups
rESWT+ and rESWT- were consistent with a Gaussian
distribution. Differences between groups were tested
with (i) Fisher’s exact test for the relative numbers of
female and male patients, (ii) Student’s t test for the
mean age of the patients and the mean interval between
the initial fracture and the first rESWT session, and (iii)
non-parametric Mann Whitney test for the mean num-
ber of rESWT sessions. In all analyses, an effect was con-
sidered statistically significant if its associated p value
was smaller than 0.05. All calculations were performed
using GraphPad Prism (version 5.00 for Windows,
GraphPad Software, San Diego, CA, USA).
Results
Six months after receiving rESWT, 16 out of 22 patients
(16/22 = 73%) had a positive outcome defined by radio-
graphic bone consolidation and the absence of both pain
and functional limitations during normal weight loading.
Treatments were well tolerated by all patients, with
bearable pain during treatment devoid of anesthesia
being the main complication reported. Neither skin
injuries nor hematomas nor ecchymosis were observed
during or after any of the rESWT sessions.
There were no statistically significant age or gender
differences observed among patients with positive
outcome (average age: 34.0 ± 4.5 years; mean ± SEM;
n = 16; 6 females, 10 males) or negative outcome (average
age: 38.7 ± 5.0 years; n = 6; three females and three males)
(age: p = 0.565; gender: p = 0.655) (Fig. 1a). Nor was there
a statistically significant difference in the mean number of
rESWT sessions applied between the groups with positive
(3.4 ± 0.2 sessions) and negative outcome (4.0 ± 0.6
sessions) (p = 0.253) (Fig. 1b). On the other hand, there
was a statistically significant difference between Groups
rESWT+ and rESWT− with respect to the time interval
between initial trauma and first application of rESWT: in
the group with positive clinical outcome this time interval
was 8.8 ± 0.8 months whereas in the group with
negative clinical outcome on average 26.0 ± 10.1 months
had passed between bone fracture and rESWT com-
mencement (p = 0.010) (Fig. 1c).
In the present study, the tibia was the most frequent
fracture nonunion site, and in 7 out of 10 tibia cases (7/
10 = 70%) rESWT yielded positive results. An impressive
case is shown in Fig. 2. This was a 14-year-old girl who
suffered in a traffic accident a combined fracture of the
left tibia and fibula (Fig. 2a). Initial surgery was
Table 2 Clinical data and treatment outcome of patients with
fracture nonunions enrolled in the present study
Case # Sex Age (years) Nonunion site Fixation I S O
1 M 38 Ulna Internal plate 7 4 +
2 M 30 Carpal scaphoid Screw fixation 5 3 +
3 F 14 Tibia Intramedullary
nail (locked)
12 4 +
4 F 21 Tibia Intramedullary
nail (locked)
9 5 +
5 F 28 Tibia Intramedullary
nail (locked)
7 3 +
6 F 43 Tibia and fibula Intramedullary
nail (tibia, locked)
5 4 +
7 M 46 Tibia Intramedullary
nail (locked)
10 2 +
8 M 48 Tibia Intramedullary
nail (locked)
9 3 +
9 M 59 Tibia Intramedullary
nail (locked)
10 4 +
10 F 58 Medial malleolus Screw fixation 14 3 +
11 M 69 Medial malleolus Screw fixation 6 3 +
12 F 15 Second metarsal Screw fixation 6 4 +
13 M 19 Fifth metatarsal Screw fixation 17 3 +
14 M 20 Fifth metatarsal Screw fixation 9 3 +
15 M 15 Iliac crest n.a. 7 3 +
16 M 21 Fibula n.a. 8 4 +
17 F 53 Clavicle Internal plate 4 2 –
18 F 19 Tibia Intramedullary
nail (locked)
18 5 –
19 M 33 Tibia (infected) Intramedullary
nail (locked),
internal plate
66 6 –
20 M 37 Tibia Intramedullary
nail (locked)
46 5 –
21 F 49 Lateral malleolus Srew fixation 6 3 –
22 M 41 Navicular bone
(foot)
Screw fixation 16 3 –
I interval between fracture and first session of radial extracorporeal shock
wave therapy (rESWT), S number of rESWT sessions, O outcome, + positive
clinical outcome, − negative clinical outcome
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performed using locked intramedullary nailing of the
tibia (Fig. 2b). Twelve months after the initial fracture
consolidation was still not achieved, and the patient
experienced severe pain during walking (Fig. 2c, d). At
this time point, a series of four rESWT sessions was
started. Six months later, the patient was pain-free
during walking, and radiographic consolidation was
achieved (Fig. 2e). Another 12 months later the intrame-
dullary nail was removed (Fig. 2f ).
Regarding those tibia patients unresponsive to rESWT, it
is noteworthy that their time interval between fracture and
rESWT commencement was on average approximately
five times higher compared to the group with positive clin-
ical outcome (i.e., 43.3 ± 13.9 months vs. 8.9 ± 0.9 months,
respectively). Furthermore, one of the unsuccessfully
treated patients showed a tibia atrophy together with a
medical history comprising eight failed previous surgeries
during an interval of 66 months, the longest interval
among all patients in the present study.
The remaining nine cases with positive clinical out-
come involved the ulna (one patient), carpal scaphoid
(one patient), inferior iliac crest (one patient), fibula
(one patient), medial malleolus (two patients), second
metatarsal bone (one patient), and fifth metatarsal
bone (two patients). In contrast, in one of each case
involving the clavicle, lateral malleolus and navicular
bone of the foot rESWT failed to achieve bony union
for unknown reasons.
Discussion
The present retrospective study, to our knowledge,
represents the first pilot case series involving more than
Fig. 1 Individual data (dots) and mean values (horizontal lines) of the
patients’ age (a), number of rESWT sessions (b), and interval between
initial fracture and the first rESWT session (c) of patients with positive
clinical outcome (Group rESWT+) and patients with negative clinical
outcome (group rESWT−). *p < 0.05
Fig. 2 Radiographs of a 14-year-old-girl who suffered in a traffic accident
a combined fracture of the left tibia and fibula, showing the situation
immediately after the accident (a) as well as 2 weeks (b), 3 months (c),
and 12 months (d) after the accident. Fracture consolidation was still not
achieved (arrows in d), and the patient experienced severe pain during
walking. At that time, a series of four rESWT sessions was started.
Six months later (e), the patient was pain-free during walking,
and radiographic consolidation was achieved (arrows in e). Another
12 months later, the intramedullary nail was removed (f)
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two patients with fracture nonunions treated with
rESWT. Sixteen out of 22 patients (73%) were success-
fully treated with rESWT, as confirmed by radiographic
consolidation at the 6-month follow-up. There were no
complications. Anesthesia during treatment was not ne-
cessary. Nonunions of the tibia were the most common
and 70% of the tibia nonunions healed within 6 months
after rESWT.
Both focused and radial extracorporeal shock waves
are single acoustic impulses with an initial high positive
peak pressure between 10 and 100 MPa reached in less
than 1 μs (reviewed in [9]). The positive pressure ampli-
tude is followed by a low tensile amplitude of a few
microseconds duration that can generate cavitation
[54–56]. They are further characterized by a short life
cycle of approximately 10–20 μs and a broad frequency
spectrum [57]. Focused ESWs differ from rESWs in the
penetration depth into the tissue, some physical character-
istics, and the technique for generating them [7, 9, 57].
We noted an association between prolonged time
interval between fracture and rESWT procedure and
failure of treatment. This discrepancy among groups
with positive and negative clinical outcome was most
pronounced in tibia cases, where unsuccessfully treated
patients displayed on average approximately five times
longer intervals than successfully treated patients. In this
respect, it is important to point out that the interval
(together with the specific type of bone affected) has been
identified as the most predictive prognostic indicator for
fracture nonunion healing at 6 months following fESWT
[39]; i.e., with intervals longer than 11 months significantly
reducing the likelihood of a positive clinical outcome (see
also [44]). In the present study, the mean interval among
the few rESWT resistant patients and particularly among
therapy resistant tibia patients exceeded this 11-month
threshold, respectively, two- and fourfold. The interval
is therefore of relevance when treating fracture
nonunions with ESWT, both in clinical routine and in
future RCTs on this topic.
Some reports in the literature [44, 58–60] referred to
the following definition of fracture nonunion provided
by the United States Food and Drug Administration
(FDA) [61]: “A non-union study would include patients
whose fractures have not healed for a minimum of nine
months and who have not undergone surgical interven-
tion during the previous three months.” It is important
to note that only two out of the 37 studies (5.4%) on
fESWT for fracture nonunions listed in Table 1 [22, 44]
adhered to this definition. In contrast, in 22 of these
studies (59.5%) a minimum time interval of 6 months
was applied to define fracture nonunions (as was done in
the present study and in the only prior report involving
the use of rESWT for treating fracture nonunions [51]
discussed below). Furthermore, in 9 out of the 37 studies
(24.3%) listed in Table 1, no definition of fracture
nonunions was provided, and in four of these studies dif-
ferent definitions of fracture nonunions were applied (de-
tails are outlined in Additional file 1). Several reasons for
this discrepancy are conceivable. Specifically, the
definition by FDA was provided without any reference to
the academic literature and was provided in a draft of a
Guidance Document that was released for comment in
1998 but has never become an official FDA Guidance
Document. Accordingly, the definition provided above
may have never become official opinion by FDA.
To our knowledge, there exists only one prior report
involving the use of rESWT for treating fracture
nonunions [51]. In this small case series of two profes-
sional dancers, rESWT was successfully used to achieve
fracture union of the base of the second metatarsal bone.
One fracture nonunion healed 3 months post treatment
and the other healed 6 months post treatment. In the
present study, the same treatment protocol as used by
Silk et al. [51] was applied (i.e., three rESWT sessions at
1-week intervals; 3000 radial extracorporeal shock waves
per session), although with a slightly lower energy flux
density (i.e., 0.18 vs. 0.20 mJ/mm2), and positive clinical
outcome was achieved in the majority of cases.
Therefore, rESWT appears to be an effective and safe
treatment option for fracture nonunions of superficial
bones in case a fESWT device is not available.
With exception of one study [51], all clinical studies
on the effects of ESWT in the treatment of fracture
nonunions have so far been conducted using fESWT
(Table 1) [10–49]. This evidence listed in PubMed as of
01 March 2017 includes one prospective RCT (level of
evidence, 1) comparing two different fESWT protocols
with surgery [10], 2 cohort studies also comparing
fESWT with surgery [11, 12], 34 case series without
control group [13–46], and 3 double publications of data
[47–49]. Collectively, these 40 studies have shown a mean
success rate of approximately 76% after 6 months.
However, this mean success rate must be interpreted
cautiously because of substantial heterogeneity of these
studies with respect to the treatment site and the fESWT
protocol used (note that in some studies [17, 18, 25, 34],
the treatment site was not specified). The success rate
reported in the RCT comparing fESWT with surgery [10]
cannot directly be compared to the results of the present
study because in the RCT, 53% of the treatment sites (67/
126) were the tibia (48% in the present study) but 27%
(34/126) were the femur, 12% (15/126) were the ulna, and
8% (10/126) were the radius (femur and radius were not
addressed in the present study). The same applies to the
success rates reported in the cohort studies comparing
fESWT with surgery because in these studies, only
patients suffering from fracture nonunions of, respectively,
the proximal fifth metatarsal [11] (only two patients in the
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present study) or the carpal scaphoid [12] (only one
patient in the present study) were included. On the other
hand, Elster et al. [37] reported for 192 fracture nonunions
of the tibia a success rate of 72% at 6 months after fESWT,
which is close to the success rate reported in the present
study. Very recently, Haffner et al. [44] reported for 52
fracture nonuions of the tibia a success rate of 89% at
6 months after fESWT, which is higher than the success
rate reported in the present study.
Based on the evidence outlined above, it appears
reasonable to propose a “therapy of first choice” recom-
mendation for the treatment of fracture nonunions using
ESWT (Fig. 3). Beforehand, it must be stressed that
ESWT for nonunions, regardless of whether fESWT or
rESWT, must be considered a medical treatment to be
performed by medical doctors with exact knowledge
about orthopedic diagnostic of nonunion and capacity to
decide the best treatment option and possible complica-
tions. This is because pain relief must not be used as
sole clinical endpoint in these cases; mainly but not
exclusively due to the analgesic effects of ESWT, usually
causing patients to mobilize the affected limb prior to
achieving bony consolidation. The recommendation
outlined in Fig. 3 considers both superficial and deep as
well as early and late fracture nonunions. In either of
these scenarios, as soon as possible after correct fracture
nonunion diagnosis, early fESWT if available should be
chosen over rESWT or surgery. If fESWT is not
available and the bone with the fracture nonunion is
superficial, early rESWT instead of surgical procedures
should be opted for. If fESWT or rESWT is not successful
in treating fracture nonunions of superficial bones then
surgical procedures should be performed.
This recommendation seems to be justified not only
from the preliminary evidence presented in the present
study but also from the increasing evidence stemming
from concerted basic research efforts into the mecha-
nisms of rESWT over the last years: (i) the application
of rESWT in deep indications such as nonunions of the
femur or avascular hip necrosis is contraindicated simply
because rESWs cannot reach the intended tissues
[55]. On the other hand, radial extracorporeal shock
waves can reach superficial bones (including those
listed in Table 2), and the results of the present study
suggest that rESWT is a safe and effective treatment
for fracture nonunions of superficial bones. (ii) For
both rESWs and fESWs, new bone formation was
demonstrated in animal models in vivo [52, 62]. (iii)
For both rESWs and fESWs, induction of proliferation
of human osteoblast like cells or primary human osteo-
blasts was shown in vitro [53, 63].
The present study is an audit of retrospectively
collected data and has therefore inherent limitations.
First, there was no randomization and no surgery arm to
this study; however, the same was the case in 92% of all
studies on fESWT for fracture nonunions (34 out of 37
studies without double publication of data). Second, the
small number of patients could potentially confound the
clinical results. Third, treatment success was determined
at 6 months after rESWT, i.e., no total success rate of
Fig. 3 Proposed decision tree for the treatment of fracture nonunions
with extracorporeal shock waves based on the evidence published so
far. fESWT focused extracorporeal shock wave therapy, rESWT radial
extracorporeal shock wave therapy
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rESWT (regardless of the follow-up interval) for fracture
nonunions could be determined. Fourth, no test of other
imaging modalities of fracture nonunions such as
computer tomography or scintigraphy was performed;
however, the symptoms and imaging findings used to
define positive clinical outcome in the present study
are generally accepted and considered appropriate for
this condition.
Conclusions
The results of the present retrospective study suggest
that rESWT is a safe and effective treatment for fracture
nonunions of superficial bones. For this reason, medical
doctors should consider rESWT prior to surgical inter-
vention in the management of fracture nonunions of
superficial bones in case fESWT is not available. In
any case, ESWT should be performed as soon as
possible after correct diagnosis of fracture nonunion.
The promising results of the present retrospective
study should encourage the implementation of RCTs
using early rESWT in the treatment of fracture
nonunions of superficial bones.
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